These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 22045709)
1. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. Gourni E; Demmer O; Schottelius M; D'Alessandria C; Schulz S; Dijkgraaf I; Schumacher U; Schwaiger M; Kessler H; Wester HJ J Nucl Med; 2011 Nov; 52(11):1803-10. PubMed ID: 22045709 [TBL] [Abstract][Full Text] [Related]
2. A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency. Osl T; Schmidt A; Schwaiger M; Schottelius M; Wester HJ Theranostics; 2020; 10(18):8264-8280. PubMed ID: 32724470 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4. Yang T; Shi D; Lin Q; Shen H; Tan H; Liu Y; Shi H; Cheng D Mol Pharm; 2024 May; 21(5):2415-2424. PubMed ID: 38606663 [TBL] [Abstract][Full Text] [Related]
4. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET. Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818 [TBL] [Abstract][Full Text] [Related]
5. [ Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614 [TBL] [Abstract][Full Text] [Related]
6. [ Konrad M; Rinscheid A; Wienand G; Nittbaur B; Wester HJ; Janzen T; Lapa C; Pfob CH; Schottelius M Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3937-3948. PubMed ID: 37597009 [TBL] [Abstract][Full Text] [Related]
7. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging. Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452 [TBL] [Abstract][Full Text] [Related]
9. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference. Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701 [TBL] [Abstract][Full Text] [Related]
10. In vivo validation of Renard I; Domarkas J; Poty S; Burke BP; Roberts DP; Goze C; Denat F; Cawthorne CJ; Archibald SJ Nucl Med Biol; 2023; 120-121():108335. PubMed ID: 37068392 [TBL] [Abstract][Full Text] [Related]
11. Validation of [ Schottelius M; Ludescher M; Richter F; Kapp TG; Kessler H; Wester HJ EJNMMI Res; 2019 Aug; 9(1):75. PubMed ID: 31410585 [TBL] [Abstract][Full Text] [Related]
12. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging. Wester HJ; Keller U; Schottelius M; Beer A; Philipp-Abbrederis K; Hoffmann F; Šimeček J; Gerngross C; Lassmann M; Herrmann K; Pellegata N; Rudelius M; Kessler H; Schwaiger M Theranostics; 2015; 5(6):618-30. PubMed ID: 25825601 [TBL] [Abstract][Full Text] [Related]
13. Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET. Lin KS; Amouroux G; Pan J; Zhang Z; Jenni S; Lau J; Liu Z; Hundal-Jabal N; Colpo N; Bénard F J Nucl Med; 2015 Apr; 56(4):622-7. PubMed ID: 25745086 [TBL] [Abstract][Full Text] [Related]
14. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer. Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139 [TBL] [Abstract][Full Text] [Related]
15. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical. Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595 [TBL] [Abstract][Full Text] [Related]
16. First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers. Vag T; Gerngross C; Herhaus P; Eiber M; Philipp-Abbrederis K; Graner FP; Ettl J; Keller U; Wester HJ; Schwaiger M J Nucl Med; 2016 May; 57(5):741-6. PubMed ID: 26769866 [TBL] [Abstract][Full Text] [Related]
17. Second generation Al Spahn MA; Luyten K; Van Loy T; Sathekge M; Deroose CM; Koole M; Schols D; Vanduffel W; De Vos K; Annaert P; Bormans G; Cleeren F Nucl Med Biol; 2024; 132-133():108906. PubMed ID: 38518400 [TBL] [Abstract][Full Text] [Related]
18. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates. Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506 [TBL] [Abstract][Full Text] [Related]
20. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]